CHRIS COVID-19 study protocol available to the scientific community
Available in Open Access, it represents a resource for researchers who want to replicate similar studies.
The CHRIS COVID-19 study started in July 2020 thanks to the Institute of Biomedicine of Eurac Research and the Health Authority of South Tyrol. Now the protocol used in the study, has been published in the journal Pathogens and Global Health to share with the scientific community the details of the study, the background and the methods used in data collection.
The CHRIS COVID-19 study is an extension of the CHRIS population study: active in the Vinschgau Valley for over ten years, it has succeeded in clinically, molecularly and genetically characterizing more than 13,000 adult participants. Over the course of a decade, information on the lifestyle and health status of each participant was collected by taking blood, urine and DNA samples, which are stored in the CHRIS biobank and available for further investigation.
Based on this pre-existing longitudinal study, it was possible to set up a sub-study focused on the spread of the new coronavirus respondig to an unprecedented health emergency. CHRIS COVID-19 is a prospective study with three main objectives:
- estimate the incidence of SARS-CoV-2 infections;
- perform a general screening of participants and their families, through the administration of questionnaires on health status, on the presence of symptoms compatible with COVID-19, on previous therapies or diseases, on lifestyle and, subsequently, also on vaccination status;
- prospectively monitor the immune response of infected participants.
Born from a collaboration between researchers and local communities, the CHRIS COVID-19 study aims to generate knowledge on the epidemiological, molecular and genetic characterization factors of COVID-19 and its long-term effects.
The full study protocol is available at this link: https://www.tandfonline.com/doi/full/10.1080/20477724.2021.1978225
Other News & Events
11 April 2022
World Parkinson’s day 2022
In time for World Parkinson’s day 2022, we present our first data utilizing a newly created C. elegans model to help prioritise a subset of PD GWAS genes worthy of further functional investigation.
21 March 2022
Epigenetic reprogramming of cancer cells by a small chemical compound
An international team of scientists, recently published a study demonstrating the beneficial effects of a particular group of chemical compounds on the epigenetic landscape in a specific and ...
28 February 2022
Two new positions opened
Job positions opened at our Institute: Biomedical laboratory technician & Technician in IT Engineering/Development/System administration.
03 February 2022
New job position
Our Institute is looking for a Senior Researcher focusing on Ethical-legal aspects of Biomedical Research. Deadline:15 March 2022
23 December 2021
Job opportunities at the Institute for Biomedicine
Are you looking for a new job challenge? We are hiring.
02 December 2021
Lo studio CHRIS riprende il follow-up dei 13 mila partecipanti
Dopo la sospensione imposta dalla pandemia, il centro CHRIS dell’Ospedale di Silandro torna a popolarsi. Per gli oltre 13 mila abitanti della Val Venosta entrati a far parte dello studio tra il 2011 e ...
14 October 2021
EPIC at the NOI project fair
The yearly EFRE project fair on October 22nd is the perfect opportunity to meet us, we are presenting EPIC at booth 13.